日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Biomarkers of response to neoadjuvant palbociclib plus anastrozole in endocrine-resistant estrogen receptor-positive/HER2-negative breast cancer: a phase 2 trial

新辅助帕博西尼联合阿那曲唑治疗内分泌耐药的雌激素受体阳性/HER2阴性乳腺癌疗效的生物标志物:一项II期试验

Kong, Tim; Mabry, Alex; Highkin, Maureen; Wang, Anthony Z; Hoog, Jeremy; Guo, Zhanfang; Gonzales-Gonzales, Adrian; Thomas, Shana; Song, Yingduo; Gao, Feng; Opyrchal, Mateusz; Peterson, Lindsay; Ademuyiwa, Foluso; Margenthaler, Julie; Aft, Rebecca; Glover-Collins, Katherine; Nehring, Leslie; Tao, Yu; Sanati, Souzan; Hagemann, Ian S; Boulos, Fouad; Holt, Matthew; Ding, Li; Zhu, Wenge; Oh, Stephen T; Wang, Jianxin; Witkiewicz, Agnieszka K; Knudsen, Erik S; Bose, Ron; Weber, Jason D; Goetz, Matthew; Northfelt, Donald; Luo, Jingqin; Ma, Cynthia X

ctDNA Analysis in ERBB2-Amplified Colorectal Cancer: Biomarker Analysis of the MyPathway Trial

ERBB2扩增型结直肠癌的ctDNA分析:MyPathway试验的生物标志物分析

Meric-Bernstam, Funda; Raghav, Kanwal Pratap Singh; Sweeney, Christopher J; Swanton, Charles; Spigel, David R; Bose, Ron; Burris, Howard A; Friedman, Claire F; Espenschied, Carin R; Grindheim, Jessica M; Malato, Julia; Schulze, Katja; Price, Richard; Kurzrock, Razelle

Detection of Circulating Tumor DNA Using a Tissue-Free Epigenomic Assay Is a Highly Prognostic Biomarker in Early-Stage Triple-Negative Breast Cancer

利用无组织表观基因组学检测方法检测循环肿瘤DNA是早期三阴性乳腺癌的一种高度预后生物标志物

Ademuyiwa, Foluso O; Ma, Cynthia X; Weilbaecher, Katherine; Suresh, Rama; Peterson, Lindsay L; Bose, Ron; Bagegni, Nusayba; Rigden, Caron E; Frith, Ashley; Clifton, Katherine; Dustin, Derek; Cai, Mingyang; Xiong, Liyang; Chen, Sai; Davis, Andrew A

Modulation of HER2 internalization enhances single-dose antibody-drug potency in HER2(+) gastric cancer.

调节 HER2 内化可增强单剂量抗体药物对 HER2(+) 胃癌的疗效

Zidel Abbey, Benton Alex, Brown Emma, Shmuel Shayla, Vanover Alex, Panikar Sandeep Surendra, Bose Ron, Park Haeseong, Davis Andrew A, Pereira Patrícia M R

Cerebellum metastasis model of HER2-positive breast cancer unveils key role of IL34-induced Arg1+ macrophages

HER2阳性乳腺癌小脑转移模型揭示IL34诱导的Arg1+巨噬细胞的关键作用

Cheng, Xiaoqing; Patel, Khooshbu Kantibhai; Zhou, Brandon; Fu, Yiwei; Cleary, Ryan; Highkin, Maureen; Hsia, Jacob; Jin, Xiaohua; Kohn, Benjamin; Prior, Julie L; Michie, Megan S; Sun, Rui; Van Swearingen, Amanda E D; Quirk, James D; Hagemann, Ian S; Li, Tristan; Jain, Vaibhav; Gregory, Simon; Kim, Albert; Bose, Ron

MyPathway Human Epidermal Growth Factor Receptor 2 Basket Study: Pertuzumab + Trastuzumab Treatment of a Tissue-Agnostic Cohort of Patients With Human Epidermal Growth Factor Receptor 2-Altered Advanced Solid Tumors

MyPathway 人类表皮生长因子受体 2 篮式研究:帕妥珠单抗 + 曲妥珠单抗治疗人类表皮生长因子受体 2 改变的晚期实体瘤患者组织学非特异性队列

Sweeney, Christopher J; Hainsworth, John D; Bose, Ron; Burris, Howard A; Kurzrock, Razelle; Swanton, Charles; Friedman, Claire F; Spigel, David R; Szado, Tania; Schulze, Katja; Price, Richard; Malato, Julia; Lo, Amy A; Levy, Jonathan; Wang, Yong; Yu, Wei; Meric-Bernstam, Funda

Adjuvant Trastuzumab Emtansine Versus Paclitaxel Plus Trastuzumab for Stage I Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: 5-Year Results and Correlative Analyses From ATEMPT

辅助曲妥珠单抗-美坦新与紫杉醇联合曲妥珠单抗治疗I期人表皮生长因子受体2阳性乳腺癌:ATEMPT研究的5年结果及相关性分析

Tarantino, Paolo; Tayob, Nabihah; Villacampa, Guillermo; Dang, Chau; Yardley, Denise A; Isakoff, Steven J; Valero, Vicente; Faggen, Meredith; Mulvey, Therese; Bose, Ron; Weckstein, Douglas; Wolff, Antonio C; Reeder-Hayes, Katherine; Rugo, Hope S; Ramaswamy, Bhuvaneswari; Zuckerman, Dan; Hart, Lowell; Gadi, Vijayakrishna K; Constantine, Michael; Cheng, Kit; Garrett, Audrey Merrill; Marcom, P Kelly; Albain, Kathy; DeFusco, Patricia; Tung, Nadine; Ardman, Blair; Nanda, Rita; Jankowitz, Rachel C; Rimawi, Mothaffar; Abramson, Vandana; Pohlmann, Paula R; Van Poznak, Catherine; Forero-Torres, Andres; Liu, Minetta C; Ruddy, Kathryn J; Waks, Adrienne G; DeMeo, Michelle; Burstein, Harold J; Partridge, Ann H; Dell'Orto, Patrizia; Russo, Leila; Krause, Emma; Newhouse, Daniel J; Kurt, Busem Binboğa; Mittendorf, Elizabeth A; Schneider, Bryan; Prat, Aleix; Winer, Eric P; Krop, Ian E; Tolaney, Sara M

Sacituzumab-govitecan-induced severe acute tubulointerstitial nephritis requiring hemodialysis

Sacituzumab-govitecan 诱发的严重急性肾小管间质性肾炎需要血液透析

Guarin, Geneva; Netzel, Audrey; Flores, Karen Marie; Cumpelik, Arun; Bose, Ron

Final findings from the CONTROL trial: Strategies to reduce the incidence and severity of neratinib-associated diarrhea in patients with HER2-positive early-stage breast cancer

CONTROL试验的最终结果:降低HER2阳性早期乳腺癌患者奈拉替尼相关性腹泻发生率和严重程度的策略

Chan, Arlene; Ruiz-Borrego, Manuel; Marx, Gavin; Chien, A Jo; Rugo, Hope S; Brufsky, Adam; Thirlwell, Michael; Trudeau, Maureen; Bose, Ron; García-Sáenz, José A; Egle, Daniel; Pistilli, Barbara; Wassermann, Johanna; Cheong, Kerry A; Schnappauf, Benjamin; Semsek, Dieter; Singer, Christian F; Foruzan, Navid; DiPrimeo, Daniel; McCulloch, Leanne; Hurvitz, Sara A; Barcenas, Carlos H

Differential chromatin accessibility and transcriptional dynamics define breast cancer subtypes and their lineages

染色质可及性和转录动力学的差异决定了乳腺癌亚型及其谱系。

Iglesia, Michael D; Jayasinghe, Reyka G; Chen, Siqi; Terekhanova, Nadezhda V; Herndon, John M; Storrs, Erik; Karpova, Alla; Zhou, Daniel Cui; Al Deen, Nataly Naser; Shinkle, Andrew T; Lu, Rita Jui-Hsien; Caravan, Wagma; Houston, Andrew; Zhao, Yanyan; Sato, Kazuhito; Lal, Preet; Street, Cherease; Rodrigues, Fernanda Martins; Southard-Smith, Austin N; Targino da Costa, André Luiz N; Zhu, Houxiang; Mo, Chia-Kuei; Crowson, Lisa; Fulton, Robert S; Wyczalkowski, Matthew A; Fronick, Catrina C; Fulton, Lucinda A; Sun, Hua; Davies, Sherri R; Appelbaum, Elizabeth L; Chasnoff, Sara E; Carmody, Madelyn; Brooks, Candace; Liu, Ruiyang; Wendl, Michael C; Oh, Clara; Bender, Diane; Cruchaga, Carlos; Harari, Oscar; Bredemeyer, Andrea; Lavine, Kory; Bose, Ron; Margenthaler, Julie; Held, Jason M; Achilefu, Samuel; Ademuyiwa, Foluso; Aft, Rebecca; Ma, Cynthia; Colditz, Graham A; Ju, Tao; Oh, Stephen T; Fitzpatrick, James; Hwang, E Shelley; Shoghi, Kooresh I; Chheda, Milan G; Veis, Deborah J; Chen, Feng; Fields, Ryan C; Gillanders, William E; Ding, Li